Texas Congresswoman Jasmine Crockett appeared as a guest on MS NOW's "Morning Joe" Friday, where she called out the Trump administration's "weaponization" of the FCC. Her comments came after "The Late ...
Trump imposed his so-called “reciprocal tariffs” in April 2025 using the International Emergency Economic Powers Act, a rule that allows the president to regulate commerce in case of a national ...
While promoting his cautionary tale about fascism, Disney asked Gilroy to refrain from using the word. Nine months after it aired its finale, the 'Star Wars' series feels scarily prescient.
3don MSN
Stephen Colbert calls out CBS for blocking interview with Democratic Senate candidate James Talarico
Late-night host Stephen Colbert was stopped from having Senate candidate James Talarico of Texas on his show Monday night because of the FCC's latest enforcement of equal-time rules.
Late-night host Stephen Colbert said his interview with Democratic Texas Senate candidate James Talarico was pulled from ...
The Texas Tribune on MSN
Stephen Colbert blasts CBS for nixing James Talarico interview
The late-night host said the network feared running afoul of new FCC guidance directing shows to give equal airtime to political candidates.
2don MSN
Questions surround hiring of teacher who left previous job after accusations of filming students
The two school districts provide conflicting information about what interaction occurred between them.
Former prime minister Malcolm Turnbull has lashed out at the Albanese government over Australia’s “dependence” on the United States.
Democratic Rep. Jasmine Crockett of Texas is urging supporters to look at experience in a heated U.S. Senate primary with ...
3don MSN
Hillary Clinton accuses Trump administration of a ‘cover-up’ over its handling of Epstein documents
Former US Secretary of State Hillary Clinton has accused the Trump administration of a “continuing cover-up” in the way it has handled the release of millions of documents relating to Jeffrey Epstein.
FDA vouchers are normally a coveted prize for biopharma companies, but a surprise rejection for Disc Medicine’s rare disease drug has biopharma reconsidering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results